A Randomized Phase III Study of Follow Up With or Without Adjuvant Gefitinib (Iressa) Following Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2012
At a glance
- Drugs Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Jul 2011 Results published in the European Journal of Cancer.
- 28 Jul 2011 Enrollment into this trial was ended prematurely with 173 patients due to low accrual, accoring to a paper published in the European Journal of Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History